Observational Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Mar 14, 2023; 29(10): 1638-1647
Published online Mar 14, 2023. doi: 10.3748/wjg.v29.i10.1638
Table 2 Diagnostic performance of the Endofaster® and rapid urease test (ProntoDry®) for the diagnosis of Helicobacter pylori infection in the study cohort, % (95%CI)

Endofaster
Rapid urease test
Overall
No PPI
Ongoing PPI therapy
Overall
No PPI
Ongoing PPI therapy
Sensitivity91.5 (79.6-97.6)97.3 (85.8-99.9)70.0 (34.8-93.3)93.6 (82.5-98.7)97.3 (85.8-99.9)80.0 (44.4-97.5)
Specificity93.0 (84.6-96.9)96.5 (87.9-99.6)89.5 (78.5-96.0)99.1 (95.2-100)100 (93.7-100)98.3 (90.6-100)
PPV84.3 (73.3-91.3)94.7 (82.2-98.6)53.9 (33.1-73.4)97.8 (86.2-99.7)100 (-)88.9 (52.8-98.3)
NPV96.4 (91.2-98.6)98.2 (88.8-99.7)94.4 (86.8-97.8)97.4 (92.7-99.1)98.3 (89.2-99.8)96.6 (89.0-99.0)
Accuracy92.6 (87.3-96.1)96.8 (91.0-99.3)86.6 (76.0-93.7)97.5 (93.8-99.3)98.9 (94.2-100)95.5 (87.5-99.1)